Table 2

Age and geographic regions of patients with metastatic colon cancer in the sensitivity analysis (Nā€‰=ā€‰600)
N (%)
All subjects 600 Individuals receiving any of the three unsupported off-label therapies 116 (19%) p-value
Age
<50 163 (27) 37 (32) 0.153
50-59 233 (39) 46 (40)
60-69 130 (22) 26 (22)
>70 62 (10) 7 (6)
Unknown 12 (2) 0
Region
Midwest 170 (28) 29 (25) 0.597
Northeast 63 (11) 13 (11)
Southeast 194 (32) 35 (30)
Southwest 68 (11) 17 (15)
West 56 (9) 14 (12)
Unknown 49 (8) 8 (7)

de Souza et al.

de Souza et al. BMC Health Services Research 2012 12:481   doi:10.1186/1472-6963-12-481

Open Data